Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection
- 27 July 2015
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 98 (6) , 1071-1080
Abstract
Hepatitis B virus is a major cause of chronic liver inflammation worldwide. Innate and adaptive immune responses work together to restrain or eliminate hepatitis B virus in the liver. Compromised or failed adaptive immune response results in persistent virus replication and spread. How to promote antiviral immunity is a research focus for hepatitis B virus prevention and therapy. In this study, we investigated the role of macrophages in the regulation of antiviral immunity. We found that F4/80+CD206+CD80lo/+ macrophages were a particular hepatic macrophage subset that expressed amphiregulin in our mouse hepatitis B virus infection model. CD206+ macrophage-derived amphiregulin promoted the immunosuppressive activity of intrahepatic regulatory T cells, demonstrated by higher expression of CTLA-4, ICOS, and CD39, as well as stronger inhibition of antiviral function of CD8+ T cells. Amphiregulin-neutralizing antibody diminished the effect of CD206+ macrophages on regulatory T cells. In addition, we found that CD206+ macrophage-derived amphiregulin activated mammalian target of rapamycin signaling in regulatory T cells, and this mammalian target of rapamycin activation was essential for promotion of regulatory T cell activity by CD206+ macrophages. Adoptive transfer of CD206+ macrophages into hepatitis B virus-infected mice increased cytoplasmic hepatitis B virus DNA in hepatocytes and also increased serum hepatitis B surface antigen. The antiviral activity of CD8+ T cells was decreased after macrophage transfer. Therefore, our research indicated that amphiregulin produced by CD206+ macrophages plays an important role in modulating regulatory T cell function and subsequently restrains the antiviral activity of CD8+ T cells. Our study offers new insights into the immunomodulation in hepatitis B virus infection.Keywords
Funding Information
- National Natural Science Foundation of China (81371789)
- Chinese Foundation for Hepatitis Prevention
- Tianqing Liver Disease Research (CFHPC20132133)
This publication has 55 references indexed in Scilit:
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- Human basophils express amphiregulin in response to T cell–derived IL-3Journal of Allergy and Clinical Immunology, 2010
- Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen speciesProceedings of the National Academy of Sciences, 2010
- Pathogenesis of hepatitis B virus infectionPathologie Biologie, 2010
- Pathogenesis of Hepatitis C Virus Infection inTupaia belangeriJournal of Virology, 2010
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Macrophages in Hepatitis B and Hepatitis C Virus InfectionsJournal of Virology, 2009
- Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtainedClinical and Experimental Immunology, 2008
- Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infectionImmunology, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005